Moleculin Biotech Inc (MBRX)
5.08
+0.05
(+0.99%)
USD |
NASDAQ |
May 17, 16:00
5.08
0.00 (0.00%)
After-Hours: 20:00
Moleculin Biotech Free Cash Flow: -24.80M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -24.80M |
| December 31, 2023 | -24.22M |
| September 30, 2023 | -25.99M |
| June 30, 2023 | -25.99M |
| March 31, 2023 | -28.91M |
| December 31, 2022 | -27.71M |
| September 30, 2022 | -24.71M |
| June 30, 2022 | -21.42M |
| March 31, 2022 | -20.14M |
| December 31, 2021 | -18.95M |
| September 30, 2021 | -17.83M |
| June 30, 2021 | -19.26M |
| March 31, 2021 | -17.43M |
| December 31, 2020 | -18.15M |
| September 30, 2020 | -19.69M |
| Date | Value |
|---|---|
| June 30, 2020 | -17.32M |
| March 31, 2020 | -17.73M |
| December 31, 2019 | -17.25M |
| September 30, 2019 | -15.79M |
| June 30, 2019 | -15.57M |
| March 31, 2019 | -13.67M |
| December 31, 2018 | -12.62M |
| September 30, 2018 | -11.80M |
| June 30, 2018 | -10.31M |
| March 31, 2018 | -8.776M |
| December 31, 2017 | -7.352M |
| September 30, 2017 | -6.126M |
| June 30, 2017 | -5.468M |
| March 31, 2017 | -4.866M |
| December 31, 2016 | -3.765M |
Free Cash Flow Range, Past 5 Years
-28.91M
Minimum
Mar 2023
-15.57M
Maximum
Jun 2019
-20.94M
Average
-19.48M
Median
Free Cash Flow Benchmarks
| Merck & Co Inc | 11.04B |
| Lixte Biotechnology Holdings Inc | -3.811M |
| Moderna Inc | -3.672B |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.717M |
| Free Cash Flow Per Share (Quarterly) | -2.724 |
| Free Cash Flow Yield | -232.2% |